SCHRODINGER INC
| Market Cap | $854.89M |
| P/E Ratio | — |
| Forward P/E | -8.39 |
| Dividend Yield | — |
| Beta | 1.62 |
| 52W Range | $11.07 - $26.69 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Health Information Services |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Bill & Melinda Gates Foundation Trust Gates Foundation Trust | 0.35% | $124.83M | 6,981,664 | — |
Insider Trading
| Insider Name of the company insider who made the trade 24 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Herman JennyCAO | Sale | 608 | $12.84 | $7.81K | 06 Mar 2026 | 06 Mar 2026 |
| Jenny HermanCAO | Sale | 608 | $12.84 | $7.81K | 06 Mar 2026 | 06 Mar 2026 |
| Akinsanya KarenSee Remarks | Sale | 1,366 | $12.90 | $17.63K | 05 Mar 2026 | 06 Mar 2026 |
| Farid RamyPresident & CEO | Sale | 3,661 | $12.91 | $47.25K | 05 Mar 2026 | 06 Mar 2026 |
| Tran YvonneEVP, CLO & CPO | Sale | 1,094 | $12.90 | $14.11K | 05 Mar 2026 | 06 Mar 2026 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Sale | 1,222 | $12.90 | $15.76K | 05 Mar 2026 | 06 Mar 2026 |
| Jain RachitEVP & CFO | Sale | 1,631 | $12.90 | $21.03K | 05 Mar 2026 | 06 Mar 2026 |
| Herman JennyCAO | Sale | 775 | $12.85 | $9.96K | 05 Mar 2026 | 06 Mar 2026 |
| Yvonne TranEVP, CLO & CPO | Sale | 1,094 | $12.90 | $14.11K | 05 Mar 2026 | 06 Mar 2026 |
| Jenny HermanCAO | Sale | 775 | $12.85 | $9.96K | 05 Mar 2026 | 06 Mar 2026 |
| Kenneth Patrick LortonEVP, CTO & COO, Software | Sale | 1,222 | $12.90 | $15.76K | 05 Mar 2026 | 06 Mar 2026 |
| Ramy FaridPresident & CEO | Sale | 3,661 | $12.91 | $47.25K | 05 Mar 2026 | 06 Mar 2026 |
| Rachit JainEVP & CFO | Sale | 1,631 | $12.90 | $21.03K | 05 Mar 2026 | 06 Mar 2026 |
| Karen AkinsanyaPresident, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Sale | 1,366 | $12.90 | $17.63K | 05 Mar 2026 | 06 Mar 2026 |
| Abel Robert LorneSee Remarks | Sale | 1,300 | $12.81 | $16.65K | 04 Mar 2026 | 06 Mar 2026 |
| Robert Lorne AbelEVP, Chief Scientific Officer, Platform | Sale | 1,300 | $12.81 | $16.65K | 04 Mar 2026 | 06 Mar 2026 |
| Farid RamyPresident & CEO | Sale | 5,560 | $11.90 | $66.15K | 02 Mar 2026 | 03 Mar 2026 |
| Akinsanya KarenSee Remarks | Sale | 2,206 | $11.99 | $26.45K | 02 Mar 2026 | 03 Mar 2026 |
| Tran YvonneEVP, CLO & CPO | Sale | 776 | $13.80 | $10.71K | 10 Feb 2026 | 12 Feb 2026 |
| Herman JennyCAO | Sale | 752 | $13.79 | $10.37K | 10 Feb 2026 | 12 Feb 2026 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Sale | 925 | $13.73 | $12.70K | 10 Feb 2026 | 12 Feb 2026 |
| Abel Robert LorneSee Remarks | Sale | 1,230 | $13.51 | $16.62K | 09 Feb 2026 | 11 Feb 2026 |
| Dugan MargaretChief Medical Officer | Sale | 1,395 | $21.07 | $29.39K | 16 Oct 2025 | 17 Oct 2025 |
| Margaret DuganChief Medical Officer | Sale | 1,395 | $21.07 | $29.39K | 16 Oct 2025 | 17 Oct 2025 |
Frequently Asked Questions
What is SDGR stock price today?
SCHRODINGER INC (SDGR) is currently trading at $11.58. The stock has a 52-week range of $11.07 to $26.69 and a market capitalization of $854.89M.
Is SDGR a good stock to buy in 2026?
SCHRODINGER INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of -38.6%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling SDGR stock?
There have been 24 insider transactions for SDGR in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has SDGR stock performed over the past year?
SCHRODINGER INC (SDGR) has returned -38.6% over the past 12 months. The stock traded between $11.07 and $26.69 during this period, and is currently at $11.58.
Which hedge funds own SDGR (SCHRODINGER INC)?
1 tracked hedge funds currently hold SDGR in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is SDGR's market cap and valuation?
SCHRODINGER INC (SDGR) has a market capitalization of $854.89M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is SDGR's revenue and profitability?
SCHRODINGER INC reported revenue of $255.87M with net income of N/A and a profit margin of N/A. The stock has a beta of 1.62.
What sector is SDGR in and who are its biggest institutional holders?
SCHRODINGER INC (SDGR) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.